2008Proceeding of Clinical MedicineRequires access

Evaluation of CD4~+CD25~+ regulatory T cells and interleukin-4 levels in peripheral blood of asthma

Yuzhang Wu

Open publisher page 0 citations

Abstract

Objective:To investigate the role of CD4+CD25+ regulatory T cells in the pathogenesis of asthma for the purpose of giving new approach of treatment.Methods:The monouclear cells were isolated from peripheral blood of asthmatic patients and control subjects,and the percentagn of CD4+CD25+ regulatory T cells was detemined by flow cytometry.The concentrations of IL-4 in PBMC supernatants were measured with enzyme linked immunosorbent assay (ELISA) method.Results:The percentage of CD4+CD25+ regulatory T cells in PBMC has significantly difference between control group(6.5±2.5)% and asthmatic patients (3.2±1.5)%(P0.05).The concentrations of IL-4 in PBMC supernatants has significantly difference between control group(28.6±7.2) ng/L and asthmatic patients(57.3±13.5) ng/L(P0.05).Conclusion:The CD4+CD25+ regulatory T cells involved in the pathogenesis of asthma in human.

About this research paper

What this paper is about

Objective:To investigate the role of CD4+CD25+ regulatory T cells in the pathogenesis of asthma for the purpose of giving new approach of treatment.Methods:The monouclear cells were isolated from peripheral blood of asthmatic patients and control subjects,and the percentagn of CD4+CD25+ regulatory T cells was detemined by flow cytometry.The concentrations of IL-4 in PBMC supernatants were measured with enzyme linked immunosorbent assay (ELISA) method.Results:The percentage of CD4+CD25+ regulatory T cells in PBMC has significantly difference between control group(6.5±2.5)% and asthmatic patients (3.2±1.5)%(P0.05).The concentrations of IL-4 in PBMC supernatants has significantly difference between control group(28.6±7.2) ng/L and asthmatic patients(57.3±13.5) ng/L(P0.05).Conclusion:The CD4+CD25+ regulatory T cells involved in the pathogenesis of asthma in human.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the role of CD4+CD25+ regulatory T cells in the pathogenesis of asthma for the purpose of giving new approach of treatment.Methods:The monouclear cells were isolated from peripheral blood of asthmatic patients and control subjects,and the percentagn of CD4+CD25+ regulatory T cells was detemined by flow cytometry.The concentrations of IL-4 in PBMC supernatants were measured with enzyme linked immunosorbent assay (ELISA) method.Results:The percentage of CD4+CD25+ regulatory T cells in PBMC has significantly difference between control group(6.5±2.5)% and asthmatic patients (3.2±1.5)%(P0.05).The concentrations of IL-4 in PBMC supernatants has significantly difference between control group(28.6±7.2) ng/L and asthmatic patients(57.3±13.5) ng/L(P0.05).Conclusion:The CD4+CD25+ regulatory T cells involved in the pathogenesis of asthma in human.

Key concepts: IL-2 receptor, Pathogenesis, Peripheral blood mononuclear cell, Flow cytometry, Immunology, Asthma, Peripheral blood, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation of CD4~+CD25~+ regulatory T cells and interleukin-4 levels in peripheral blood of asthma — Research Paper | ScholarLens